Universal-Beteiligungs- und Servicegesellschaft’s Cabaletta Bio CABA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Buy	+54,086	New	+$178K	﹤0.01%	2050

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CABA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft opened a new position in Cabaletta Bio (CABA) in Q2 2026: 54,086 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #2050 among its holdings.

140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 54,086 shares of Cabaletta Bio worth $168K as of Q2 2026.
Cabaletta Bio was a new Universal-Beteiligungs- und Servicegesellschaft position in Q2 2026.
Cabaletta Bio made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2050 holding.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.